Skip to main content

Stay Current With Rectal Cancer Treatment Advances & Connect with Others

CancerConnect Rectal Cancer Newsletter

CancerConnect publishes daily cancer news, original articles and "tips" on the management of Rectal Cancer. These are available in our monthly Rectal Cancer newsletter.

Stay Current - Connect With Other Rectal Cancer Patients

Join The CancerConnect Community: Connect with others and receive regular updates


Scroll to Continue

Recommended Articles

Image placeholder title

Sarclisa (isatuximab) – Anti CD38 Targeted Therapy for Myeloma

Sarclisa precision cancer medicine improves survival in advanced Multiple Myeloma - leads to FDA approval

Sign up for the Rectal Cancer Newsletter Here